These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36614118)

  • 61. A robust TDP-43 knock-in mouse model of ALS.
    Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
    Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pathological and immunoblot analysis of phosphorylated TDP-43 in sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration.
    Uchino A; Ogino M; Takahashi-Fujigasaki J; Oonuma S; Kanazawa N; Kajita S; Ichinoe M; Hasegawa M; Nishiyama K; Murayama S
    Neuropathology; 2018 Apr; 38(2):171-178. PubMed ID: 28906030
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
    Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
    Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro.
    Winton MJ; Van Deerlin VM; Kwong LK; Yuan W; Wood EM; Yu CE; Schellenberg GD; Rademakers R; Caselli R; Karydas A; Trojanowski JQ; Miller BL; Lee VM
    FEBS Lett; 2008 Jun; 582(15):2252-6. PubMed ID: 18505686
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
    Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
    J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 67. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD.
    Tamaki Y; Urushitani M
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293362
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex.
    Dyer MS; Reale LA; Lewis KE; Walker AK; Dickson TC; Woodhouse A; Blizzard CA
    J Neurochem; 2021 May; 157(4):1300-1315. PubMed ID: 33064315
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis.
    Smethurst P; Risse E; Tyzack GE; Mitchell JS; Taha DM; Chen YR; Newcombe J; Collinge J; Sidle K; Patani R
    Brain; 2020 Feb; 143(2):430-440. PubMed ID: 32040555
    [TBL] [Abstract][Full Text] [Related]  

  • 71. TAR DNA-binding protein 43 in neurodegenerative disease.
    Chen-Plotkin AS; Lee VM; Trojanowski JQ
    Nat Rev Neurol; 2010 Apr; 6(4):211-20. PubMed ID: 20234357
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
    Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
    Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies.
    Wu CC; Jin LW; Wang IF; Wei WY; Ho PC; Liu YC; Tsai KJ
    EMBO Mol Med; 2020 Jun; 12(6):e10622. PubMed ID: 32449313
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biochemical and histopathological alterations in TAR DNA-binding protein-43 after acute ischemic stroke in rats.
    Kanazawa M; Kakita A; Igarashi H; Takahashi T; Kawamura K; Takahashi H; Nakada T; Nishizawa M; Shimohata T
    J Neurochem; 2011 Mar; 116(6):957-65. PubMed ID: 20557425
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM
    Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43
    Chand KK; Lee KM; Lee JD; Qiu H; Willis EF; Lavidis NA; Hilliard MA; Noakes PG
    FASEB J; 2018 May; 32(5):2676-2689. PubMed ID: 29295857
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Neuropathology of TDP-43 proteinopathy].
    Akiyama H; Hasegawa M
    Brain Nerve; 2013 Dec; 65(12):1477-89. PubMed ID: 24323933
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phosphorylated TAR DNA-binding protein-43: Aggregation and antibody-based inhibition.
    Esposto JC; Martic S
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166234. PubMed ID: 34339840
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons.
    Han JH; Yu TH; Ryu HH; Jun MH; Ban BK; Jang DJ; Lee JA
    Exp Cell Res; 2013 Aug; 319(13):1998-2005. PubMed ID: 23742895
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis.
    Lanznaster D; Bourgeais J; Bruno C; Hergesheimer RC; Thepault RA; Vourc'h P; Corcia P; Andres CR; Herault O; Blasco H
    Cells; 2019 Dec; 9(1):. PubMed ID: 31888078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.